赤藓糖醇
内分泌学
内科学
脂肪组织
生物
脂肪肝
白色脂肪组织
小肠
生物化学
医学
疾病
作者
Rena Kawano,Takuro Okamura,Yoshitaka Hashimoto,Saori Majima,Takafumi Senmaru,Emi Ushigome,Mai Asano,Masahiro Yamazaki,Hiroshi Takakuwa,Ryoichi Sasano,Naoko Nakanishi,Masahide Hamaguchi,Michiaki Fukui
摘要
BACKGROUND: Erythritol, a sugar alcohol, is widely used as a substitute for sugar in diets for patients with diabetes or obesity. METHODS: In this study, we aimed to investigate the effects of erythritol on metabolic disorders induced by a high-fat diet in C57BL/6J mice, while focusing on changes in innate immunity. RESULTS: = 6). Furthermore, compared with the Ctrl group, the Ery group had lesser fat deposition in the liver, smaller adipocytes, and significantly better inflammatory findings in the small intestine. The concentrations of short-chain fatty acids (SCFAs), such as acetic acid, propanoic acid, and butanoic acid, in the serum, feces, and white adipose tissue of the Ery group were markedly higher than those in the Ctrl group. In flow cytometry experiments, group 3 innate lymphoid cell (ILC3) counts in the lamina propria of the small intestine and ILC2 counts in the white adipose tissue of the Ery group were markedly higher than those in the Ctrl group. Quantitative real-time reverse transcription polymerase chain reaction analyses showed that the Il-22 expression in the small intestine of the Ery group was markedly higher than that in the Ctrl group. CONCLUSIONS: Erythritol markedly decreased metabolic disorders such as diet-induced obesity, glucose intolerance, dyslipidemia, and fat accumulation in the mouse liver by increasing SCFAs and modulating innate immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI